Pub Date : 2025-09-19eCollection Date: 2025-01-01DOI: 10.1159/000546786
Mohammed-Nabil Kaliche, Jean-Philippe Nordmann, Marc Putterman, Thien-Huong Nguyen, Amin Bennedjai
Introduction: This case report details a pseudotumoral lesion of the lacrimal sac, serving as the initial manifestation of seronegative IgG4 disease.
Case presentation: A 36-year-old female, without notable medical history, presented with a swelling located near the inner canthus and lacrimal crest associated with pain and skin redness. Despite two rounds of antibiotics, there was no improvement. Initially diagnosed as chronic dacryocystitis, antibiotic therapy with amoxicillin clavulanate was continued, and an orbital MRI was conducted for further evaluation. The MRI revealed a fibrous tissue process adjacent to the lacrimal sac, raising suspicion of malignancy. A biopsy under general anesthesia was performed due to a strong suspicion of squamous cell carcinoma of the sac. Biopsy revealed lymphoplasmacytic infiltration and storiform fibrosis, meeting ACR/EULAR criteria for IgG4 disease. Internal medicine evaluation found no extralacrimal organ involvement, and serum IgG levels were normal. Diagnostic criteria, including clinical presentation, imaging review, histological features, and exclusion criteria, confirmed IgG4 disease and ruled out malignancy. Systemic corticosteroid therapy resulted in rapid clinical improvement, supporting the diagnosis.
Conclusion: This case underscores the diagnostic challenges of IgG4 disease, emphasizing the importance of a comprehensive approach, including histological confirmation. Distinguishing it from malignancies is crucial, and biopsy should be considered in cases of diagnostic uncertainty before invasive or systemic treatments for suspected tumors.
{"title":"Pseudotumoral Lesion of the Lacrimal Sac Unveiling Seronegative IgG4-Related Disease: A Diagnostic Challenge.","authors":"Mohammed-Nabil Kaliche, Jean-Philippe Nordmann, Marc Putterman, Thien-Huong Nguyen, Amin Bennedjai","doi":"10.1159/000546786","DOIUrl":"10.1159/000546786","url":null,"abstract":"<p><strong>Introduction: </strong>This case report details a pseudotumoral lesion of the lacrimal sac, serving as the initial manifestation of seronegative IgG4 disease.</p><p><strong>Case presentation: </strong>A 36-year-old female, without notable medical history, presented with a swelling located near the inner canthus and lacrimal crest associated with pain and skin redness. Despite two rounds of antibiotics, there was no improvement. Initially diagnosed as chronic dacryocystitis, antibiotic therapy with amoxicillin clavulanate was continued, and an orbital MRI was conducted for further evaluation. The MRI revealed a fibrous tissue process adjacent to the lacrimal sac, raising suspicion of malignancy. A biopsy under general anesthesia was performed due to a strong suspicion of squamous cell carcinoma of the sac. Biopsy revealed lymphoplasmacytic infiltration and storiform fibrosis, meeting ACR/EULAR criteria for IgG4 disease. Internal medicine evaluation found no extralacrimal organ involvement, and serum IgG levels were normal. Diagnostic criteria, including clinical presentation, imaging review, histological features, and exclusion criteria, confirmed IgG4 disease and ruled out malignancy. Systemic corticosteroid therapy resulted in rapid clinical improvement, supporting the diagnosis.</p><p><strong>Conclusion: </strong>This case underscores the diagnostic challenges of IgG4 disease, emphasizing the importance of a comprehensive approach, including histological confirmation. Distinguishing it from malignancies is crucial, and biopsy should be considered in cases of diagnostic uncertainty before invasive or systemic treatments for suspected tumors.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"745-751"},"PeriodicalIF":0.6,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659169/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: This article presents the results of a prospective pilot study on circulating tumor DNA (ctDNA) monitoring in uveal melanoma (UM) patients, along with a systematic review of the literature to support and contextualize the findings. We investigated the clinical utility of ctDNA variant allele frequency (VAF) for early detection of tumor progression.
Case presentations: We performed serial ctDNA testing using the Ion AmpliSeq Cancer Hotspot Panel v2 and Ion Proton™ sequencing in 3 UM patients (two recurrent, one nonrecurrent) at four time points over 2 years. A systematic review of studies up to June 2024 was also conducted, identifying 32 additional UM patients. In recurrent patients, co-occurring mutations in GNAQ, GNAS, and IDH1 were identified at the time of recurrence, with minimum VAFs of 0.51%, 0.25%, and 0.1%, respectively. In the nonrecurrent patient, pathogenic variants were absent, and VAFs of key genes declined over time. The systematic review supported the association of ctDNA alterations with recurrence and metastasis, identifying critical genes including GNAQ/11, GNAS, IDH1, STK11, FGFR2, and EGFR, many of which interact with the BAP1 signaling pathway.
Conclusion: Serial ctDNA analysis may serve as a noninvasive tool for early detection of recurrence in UM. Co-occurrence of GNAQ, GNAS, and IDH1 mutations may represent a molecular signature of recurrence. Further validation in larger cohorts is needed to define optimal gene panels and VAF thresholds for clinical use.
本文介绍了一项关于葡萄膜黑色素瘤(UM)患者循环肿瘤DNA (ctDNA)监测的前瞻性先导研究的结果,并对文献进行了系统回顾,以支持和背景化这些发现。我们研究了ctDNA变异等位基因频率(VAF)在早期检测肿瘤进展中的临床应用。病例介绍:我们使用Ion AmpliSeq Cancer Hotspot Panel v2和Ion Proton™测序对3例UM患者(2例复发,1例非复发)在2年内的4个时间点进行了连续ctDNA检测。对截至2024年6月的研究进行了系统评价,确定了32名额外的UM患者。在复发患者中,在复发时发现GNAQ、GNAS和IDH1共发生突变,最小VAFs分别为0.51%、0.25%和0.1%。在非复发患者中,致病变异不存在,关键基因的VAFs随时间下降。系统评价支持ctDNA改变与复发和转移的关联,鉴定出关键基因包括GNAQ/11、GNAS、IDH1、STK11、FGFR2和EGFR,其中许多与BAP1信号通路相互作用。结论:序列ctDNA分析可作为早期发现UM复发的无创工具。GNAQ, GNAS和IDH1突变的共同出现可能代表复发的分子特征。需要在更大的队列中进一步验证,以确定临床使用的最佳基因组和VAF阈值。
{"title":"The Value of Detecting and Monitoring ctDNA in Uveal Melanoma: Results of a Pilot Study and a Systematic Review.","authors":"Fatemeh Azimi, Saeed Talebi, Reza Mirshahi, Golnaz Khakpoor, Masood Naseripour","doi":"10.1159/000548442","DOIUrl":"10.1159/000548442","url":null,"abstract":"<p><strong>Introduction: </strong>This article presents the results of a prospective pilot study on circulating tumor DNA (ctDNA) monitoring in uveal melanoma (UM) patients, along with a systematic review of the literature to support and contextualize the findings. We investigated the clinical utility of ctDNA variant allele frequency (VAF) for early detection of tumor progression.</p><p><strong>Case presentations: </strong>We performed serial ctDNA testing using the Ion AmpliSeq Cancer Hotspot Panel v2 and Ion Proton™ sequencing in 3 UM patients (two recurrent, one nonrecurrent) at four time points over 2 years. A systematic review of studies up to June 2024 was also conducted, identifying 32 additional UM patients. In recurrent patients, co-occurring mutations in <i>GNAQ</i>, <i>GNAS</i>, and <i>IDH1</i> were identified at the time of recurrence, with minimum VAFs of 0.51%, 0.25%, and 0.1%, respectively. In the nonrecurrent patient, pathogenic variants were absent, and VAFs of key genes declined over time. The systematic review supported the association of ctDNA alterations with recurrence and metastasis, identifying critical genes including <i>GNAQ/11</i>, <i>GNAS</i>, <i>IDH1</i>, <i>STK11</i>, <i>FGFR2</i>, and <i>EGFR</i>, many of which interact with the BAP1 signaling pathway.</p><p><strong>Conclusion: </strong>Serial ctDNA analysis may serve as a noninvasive tool for early detection of recurrence in UM. Co-occurrence of <i>GNAQ</i>, <i>GNAS</i>, and <i>IDH1</i> mutations may represent a molecular signature of recurrence. Further validation in larger cohorts is needed to define optimal gene panels and VAF thresholds for clinical use.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"791-806"},"PeriodicalIF":0.6,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659632/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11eCollection Date: 2025-01-01DOI: 10.1159/000548315
Daniella Socci da Costa, Remo Turchetti Moraes, Moyses Eduardo Zajdenweber, André Luiz Land Curi, Jamison Menezes de Souza, Aluisio Rosa Gameiro Filho
Introduction: The aim of this study was to report an unusual case of a presumed paraneoplastic syndrome associated with Hodgkin lymphoma (HL).
Case presentation: An otherwise healthy 18-year-old male patient presented with progressive bilateral visual loss over a 2-month period. Fundus examination revealed multiple yellow-whitish lesions in both eyes, resembling multifocal choroiditis. Over time, the patient developed subretinal fibrosis and a palpable cervical lymph node, which was biopsied, confirming the diagnosis of HL.
Conclusion: Ocular involvement in HL is exceedingly rare and may manifest with a wide range of signs and symptoms. Paraneoplastic inflammatory syndromes should be considered by ophthalmologists in patients with atypical bilateral posterior uveitis.
{"title":"Progressive Subretinal Fibrosis and Uveitis Associated with Hodgkin Lymphoma.","authors":"Daniella Socci da Costa, Remo Turchetti Moraes, Moyses Eduardo Zajdenweber, André Luiz Land Curi, Jamison Menezes de Souza, Aluisio Rosa Gameiro Filho","doi":"10.1159/000548315","DOIUrl":"10.1159/000548315","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to report an unusual case of a presumed paraneoplastic syndrome associated with Hodgkin lymphoma (HL).</p><p><strong>Case presentation: </strong>An otherwise healthy 18-year-old male patient presented with progressive bilateral visual loss over a 2-month period. Fundus examination revealed multiple yellow-whitish lesions in both eyes, resembling multifocal choroiditis. Over time, the patient developed subretinal fibrosis and a palpable cervical lymph node, which was biopsied, confirming the diagnosis of HL.</p><p><strong>Conclusion: </strong>Ocular involvement in HL is exceedingly rare and may manifest with a wide range of signs and symptoms. Paraneoplastic inflammatory syndromes should be considered by ophthalmologists in patients with atypical bilateral posterior uveitis.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"728-738"},"PeriodicalIF":0.6,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11eCollection Date: 2025-01-01DOI: 10.1159/000547547
Tatsuya Yunoki, Aya Taniguchi, Atsushi Hayashi
Introduction: Herein, we report a case of recurrent and metastatic sebaceous gland carcinoma (SGC) following orbital exenteration, which was managed with S-1 administration.
Case presentation: The patient was a 78-year-old man. At the initial examination, the extension of SGC into the right orbit was noted, for which radiotherapy, instead of orbital exenteration, was administered as per patient preference. However, after 2 years, the tumor enlarged, necessitating right orbital exenteration. Six months after the procedure, recurrence with orbital apex involvement, invasion into the supraorbital wall, and metastasis to the right cervical lymph nodes were observed. Therefore, resection of the supraorbital wall and temporalis muscle skin valve and dissection of the right cervical lymph nodes were performed. Seven months later, positron emission tomography/computed tomography revealed intraorbital recurrence, right submandibular gland metastasis, and lung metastasis. Accordingly, S-1 treatment was initiated, following which the intraorbital lesions and metastases disappeared; the patient remained in remission over 1 year later.
Conclusion: Our findings suggest that S-1 treatment may be effective in the management of refractory SGC.
{"title":"Efficacy of S-1 Treatment in Recurrent and Metastatic Orbital Sebaceous Gland Carcinoma after Orbital Exenteration.","authors":"Tatsuya Yunoki, Aya Taniguchi, Atsushi Hayashi","doi":"10.1159/000547547","DOIUrl":"10.1159/000547547","url":null,"abstract":"<p><strong>Introduction: </strong>Herein, we report a case of recurrent and metastatic sebaceous gland carcinoma (SGC) following orbital exenteration, which was managed with S-1 administration.</p><p><strong>Case presentation: </strong>The patient was a 78-year-old man. At the initial examination, the extension of SGC into the right orbit was noted, for which radiotherapy, instead of orbital exenteration, was administered as per patient preference. However, after 2 years, the tumor enlarged, necessitating right orbital exenteration. Six months after the procedure, recurrence with orbital apex involvement, invasion into the supraorbital wall, and metastasis to the right cervical lymph nodes were observed. Therefore, resection of the supraorbital wall and temporalis muscle skin valve and dissection of the right cervical lymph nodes were performed. Seven months later, positron emission tomography/computed tomography revealed intraorbital recurrence, right submandibular gland metastasis, and lung metastasis. Accordingly, S-1 treatment was initiated, following which the intraorbital lesions and metastases disappeared; the patient remained in remission over 1 year later.</p><p><strong>Conclusion: </strong>Our findings suggest that S-1 treatment may be effective in the management of refractory SGC.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"739-744"},"PeriodicalIF":0.6,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-09eCollection Date: 2025-01-01DOI: 10.1159/000548364
Tokuhide Oyama, Makoto Miyajima, Ayako Tazawa
Introduction: Basal cell adenoma (BCA) is a rare benign tumor of the salivary gland, reported to account for 1-3% of all salivary gland tumors, and is the third most common benign salivary gland tumor after pleomorphic adenoma (PA) and Warthin's tumor. We present the first case of a primary BCA of the lacrimal gland, an extremely rare condition, which is very similar in clinical presentation to PA of the lacrimal gland tumor.
Case presentation: An 18-year-old male patient experienced mild right proptosis for 3 years, without diplopia or pain. Orbital CT showed partial bone erosion, and MRI showed a 16 × 18 × 25 mm lobulated, well-defined mass. Anterior orbitotomy was performed to totally remove the entire lacrimal gland tumor along with its surrounding periosteum. Histopathological exams revealed a biphasic pattern of solid and cribriform, with no evidence of perineural invasion, vascular invasion, or invasion of surrounding tissues. The cell membrane and many nuclei of the tumor cells were positive for β-catenin.
Conclusion: BCA is a very rare tumor of the lacrimal gland, but complete resection is the effective treatment. Postoperative follow-up is necessary due to the possibility of malignant transformation.
{"title":"Primary Basal Cell Adenoma of the Lacrimal Gland: A Rare Case.","authors":"Tokuhide Oyama, Makoto Miyajima, Ayako Tazawa","doi":"10.1159/000548364","DOIUrl":"10.1159/000548364","url":null,"abstract":"<p><strong>Introduction: </strong>Basal cell adenoma (BCA) is a rare benign tumor of the salivary gland, reported to account for 1-3% of all salivary gland tumors, and is the third most common benign salivary gland tumor after pleomorphic adenoma (PA) and Warthin's tumor. We present the first case of a primary BCA of the lacrimal gland, an extremely rare condition, which is very similar in clinical presentation to PA of the lacrimal gland tumor.</p><p><strong>Case presentation: </strong>An 18-year-old male patient experienced mild right proptosis for 3 years, without diplopia or pain. Orbital CT showed partial bone erosion, and MRI showed a 16 × 18 × 25 mm lobulated, well-defined mass. Anterior orbitotomy was performed to totally remove the entire lacrimal gland tumor along with its surrounding periosteum. Histopathological exams revealed a biphasic pattern of solid and cribriform, with no evidence of perineural invasion, vascular invasion, or invasion of surrounding tissues. The cell membrane and many nuclei of the tumor cells were positive for β-catenin.</p><p><strong>Conclusion: </strong>BCA is a very rare tumor of the lacrimal gland, but complete resection is the effective treatment. Postoperative follow-up is necessary due to the possibility of malignant transformation.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"752-758"},"PeriodicalIF":0.6,"publicationDate":"2025-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-04eCollection Date: 2025-01-01DOI: 10.1159/000548289
Xuhua Zhao, Xinyue Zhu, Chunyu Liang, Pengyi Zhou, Kunpeng Xie, Bo Jin, Haiyan Zhu, Fuzhen Li, Yuying Wang, Leite Shi, Bo Lei, Xiaofeng Wang, Liping Du, Lin Li, Xuemin Jin
Introduction: The extraction of intraocular foreign bodies (IOFBs) presents a significant challenge in ocular surgery. This report introduces a novel magnetic foreign body extractor, specifically designed for the removal of small- to medium-sized magnetic IOFBs located in the posterior segment of the eye.
Case presentations: Our report presents 2 cases of IOFB removal using a novel magnetic foreign body extractor, performed in conjunction with pars plana vitrectomy (PPV). The IOFBs were successfully removed through corneal or limbal incisions with a 23-gauge rechargeable magnetic foreign body extractor, without the need to enlarge the scleral incision. All procedures were completed independently, without the use of additional instruments, resulting in no instances of iatrogenic retinal injury, vitreous incarceration, or postoperative proliferative vitreoretinopathy. Furthermore, both patients showed significant visual improvement, with best-corrected visual acuity improving from counting fingers preoperatively to 0.6 and 0.7 at the 1-month follow-up.
Conclusion: The magnetizable intraocular magnetic foreign body extractor, in combination with minimally invasive vitrectomy techniques, offers a safe and effective solution for the removal of magnetic IOFBs in the posterior segment of the eye. This approach not only enhances visual acuity but also reduces the risk of postoperative complications, highlighting its potential as a valuable tool in ocular trauma management.
{"title":"Extraction of Magnetic Intraocular Foreign Bodies Using a Novel Magnetic Foreign Body Extractor: 2 Cases.","authors":"Xuhua Zhao, Xinyue Zhu, Chunyu Liang, Pengyi Zhou, Kunpeng Xie, Bo Jin, Haiyan Zhu, Fuzhen Li, Yuying Wang, Leite Shi, Bo Lei, Xiaofeng Wang, Liping Du, Lin Li, Xuemin Jin","doi":"10.1159/000548289","DOIUrl":"10.1159/000548289","url":null,"abstract":"<p><strong>Introduction: </strong>The extraction of intraocular foreign bodies (IOFBs) presents a significant challenge in ocular surgery. This report introduces a novel magnetic foreign body extractor, specifically designed for the removal of small- to medium-sized magnetic IOFBs located in the posterior segment of the eye.</p><p><strong>Case presentations: </strong>Our report presents 2 cases of IOFB removal using a novel magnetic foreign body extractor, performed in conjunction with pars plana vitrectomy (PPV). The IOFBs were successfully removed through corneal or limbal incisions with a 23-gauge rechargeable magnetic foreign body extractor, without the need to enlarge the scleral incision. All procedures were completed independently, without the use of additional instruments, resulting in no instances of iatrogenic retinal injury, vitreous incarceration, or postoperative proliferative vitreoretinopathy. Furthermore, both patients showed significant visual improvement, with best-corrected visual acuity improving from counting fingers preoperatively to 0.6 and 0.7 at the 1-month follow-up.</p><p><strong>Conclusion: </strong>The magnetizable intraocular magnetic foreign body extractor, in combination with minimally invasive vitrectomy techniques, offers a safe and effective solution for the removal of magnetic IOFBs in the posterior segment of the eye. This approach not only enhances visual acuity but also reduces the risk of postoperative complications, highlighting its potential as a valuable tool in ocular trauma management.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"720-727"},"PeriodicalIF":0.6,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12659014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145647593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-01eCollection Date: 2025-01-01DOI: 10.1159/000547387
Sigrid Aslaksen, Eirik Bratland, Mari Hamre Bu, Ingvild Aukrust, Cecilie Bredrup, Marte Innselset Flydal, Adam P DeLuca, Jeaneen L Andorf, Edwin M Stone, Per Morten Knappskog
Introduction: Biallelic pathogenic variants in the ABCA4 gene are the leading cause of inherited retinal diseases. Over 1,200 pathogenic or likely pathogenic ABCA4 variants have been reported, resulting in a broad clinical spectrum of ABCA4-retinal dystrophies (ABCA4-RD), with Stargardt disease being the most common. Most patients with ABCA4-RD are compound heterozygotes, carrying two pathogenic ABCA4 variants in trans.
Case presentation: We report 2 unrelated patients with early-onset (≤12 years) Stargardt disease, both found to be homozygous for a complex ABCA4 allele containing the hypomorphic c.5882G>A p.(Gly1961Glu) variant and the c.634C>T p.(Arg212Cys) variant. Both patients underwent detailed clinical assessment and genetic screening, including whole exome or genome sequencing. In vitro assays were performed to assess the individual and combined effect of these variants on the ABCA4 protein. The identified ABCA4 variants were expressed in HEK293FT and HeLa cells to assess their protein expression levels and intracellular localization compared to the wild type (WT) ABCA4 protein. Molecular analysis revealed that the Arg212Cys variant and the doubly mutated allele showed similarly reduced protein expression, while Gly1961Glu expressed close to WT level. Both variants, individually and combined, localized to intracellular vesicles similarly to WT ABCA4.
Conclusion: This study highlights the genetic complexity of ABCA4-RD and the significance of pathogenic variants in cis. It also emphasizes the challenge of accurately predicting the functional consequences of specific ABCA4 alleles with in vitro assays.
ABCA4基因的双等位致病变异是遗传性视网膜疾病的主要原因。据报道,超过1200种致病性或可能致病性的ABCA4变异导致ABCA4-视网膜营养不良(ABCA4- rd)的广泛临床谱,其中Stargardt病是最常见的。大多数ABCA4- rd患者为复合杂合子,反式携带两种致病性ABCA4变体。病例介绍:我们报告了2例不相关的早发性(≤12岁)Stargardt病患者,均发现一个复杂的ABCA4等位基因纯合子,该等位基因含有半形的c.5882G> a p (Gly1961Glu)变体和c.634C>T p (Arg212Cys)变体。两名患者都接受了详细的临床评估和基因筛查,包括全外显子组或基因组测序。进行体外试验以评估这些变异对ABCA4蛋白的单独和联合影响。鉴定出的ABCA4变体在HEK293FT和HeLa细胞中表达,与野生型(WT) ABCA4蛋白相比,评估其蛋白表达水平和细胞内定位。分子分析显示,Arg212Cys变体和双突变等位基因表达相似,Gly1961Glu表达接近WT水平。这两种变体,单独或联合,定位于细胞内囊泡类似于WT ABCA4。结论:本研究突出了ABCA4-RD的遗传复杂性和致病变异在cis中的意义。它还强调了用体外检测准确预测特定ABCA4等位基因功能后果的挑战。
{"title":"Early-Onset Stargardt Disease Caused by Homozygosity of a Complex <i>ABCA4</i> Allele from Eastern Africa: Two Case Reports.","authors":"Sigrid Aslaksen, Eirik Bratland, Mari Hamre Bu, Ingvild Aukrust, Cecilie Bredrup, Marte Innselset Flydal, Adam P DeLuca, Jeaneen L Andorf, Edwin M Stone, Per Morten Knappskog","doi":"10.1159/000547387","DOIUrl":"10.1159/000547387","url":null,"abstract":"<p><strong>Introduction: </strong>Biallelic pathogenic variants in the <i>ABCA4</i> gene are the leading cause of inherited retinal diseases. Over 1,200 pathogenic or likely pathogenic <i>ABCA4</i> variants have been reported, resulting in a broad clinical spectrum of <i>ABCA4</i>-retinal dystrophies (ABCA4-RD), with Stargardt disease being the most common. Most patients with ABCA4-RD are compound heterozygotes, carrying two pathogenic <i>ABCA4</i> variants in <i>trans.</i></p><p><strong>Case presentation: </strong>We report 2 unrelated patients with early-onset (≤12 years) Stargardt disease, both found to be homozygous for a complex <i>ABCA4</i> allele containing the hypomorphic c.5882G>A p.(Gly1961Glu) variant and the c.634C>T p.(Arg212Cys) variant. Both patients underwent detailed clinical assessment and genetic screening, including whole exome or genome sequencing. In vitro assays were performed to assess the individual and combined effect of these variants on the ABCA4 protein. The identified <i>ABCA4</i> variants were expressed in HEK293FT and HeLa cells to assess their protein expression levels and intracellular localization compared to the wild type (WT) ABCA4 protein. Molecular analysis revealed that the Arg212Cys variant and the doubly mutated allele showed similarly reduced protein expression, while Gly1961Glu expressed close to WT level. Both variants, individually and combined, localized to intracellular vesicles similarly to WT ABCA4.</p><p><strong>Conclusion: </strong>This study highlights the genetic complexity of ABCA4-RD and the significance of pathogenic variants in <i>cis</i>. It also emphasizes the challenge of accurately predicting the functional consequences of specific <i>ABCA4</i> alleles with in vitro assays.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"661-670"},"PeriodicalIF":0.6,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503724/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-29eCollection Date: 2025-01-01DOI: 10.1159/000547058
Veshesh Patel, Anny M S Cheng, Joby Tsai, Woon Nam Chow, Ricardo J Komotar, Arash Maleki, Scott Schecter
Introduction: Differentiating non-glaucomatous and glaucomatous etiologies of optic neuropathy clinically can be challenging. We describe a patient with glaucoma and a concurrent planum sphenoidale meningioma to highlight the importance of fundoscopic examination and ancillary diagnostic tests. Despite thinning of the retinal nerve fiber layers (RNFL), tumor resection led to encouraging improvement in postoperative visual field (VF) testing. This suggests that the presence of reasonably preserved nerve fiber layers is a prognostic factor for visual field recovery following neurosurgical intervention in cases involving the chiasmal region.
Case presentation: A 73-year-old female presented with a 1-year history of headaches, intermittent ocular pain, blurred vision, and gradual loss of peripheral vision in her left eye. Initial evaluation revealed normal intraocular pressure and asymmetric cupping of 0.6 and 0.4 in the right and left eyes, respectively. While normal tension glaucoma was a possible diagnosis, her bilateral optic nerve head pallor, thinning of the RNFL, and VF defects that did not match the cupping raise suspicion of an intracranial lesion. Magnetic resonance imaging (MRI) and histopathology confirmed a large planum sphenoidale meningioma, which was surgically resected. Postoperative recovery showed drastically improved VF and resolution of symptoms, though visual acuity remained suboptimal.
Conclusion: Surgical resection of a large tumor size, as seen in our patient, can still result in visual field improvement despite suboptimal recovery of visual acuity. This case highlights the importance of considering intracranial tumors in the differential diagnosis to prevent long-term visual impairment.
{"title":"Large Planum Sphenoidale Meningioma in a Patient with Bilateral Optic Disc Pallor.","authors":"Veshesh Patel, Anny M S Cheng, Joby Tsai, Woon Nam Chow, Ricardo J Komotar, Arash Maleki, Scott Schecter","doi":"10.1159/000547058","DOIUrl":"10.1159/000547058","url":null,"abstract":"<p><strong>Introduction: </strong>Differentiating non-glaucomatous and glaucomatous etiologies of optic neuropathy clinically can be challenging. We describe a patient with glaucoma and a concurrent planum sphenoidale meningioma to highlight the importance of fundoscopic examination and ancillary diagnostic tests. Despite thinning of the retinal nerve fiber layers (RNFL), tumor resection led to encouraging improvement in postoperative visual field (VF) testing. This suggests that the presence of reasonably preserved nerve fiber layers is a prognostic factor for visual field recovery following neurosurgical intervention in cases involving the chiasmal region.</p><p><strong>Case presentation: </strong>A 73-year-old female presented with a 1-year history of headaches, intermittent ocular pain, blurred vision, and gradual loss of peripheral vision in her left eye. Initial evaluation revealed normal intraocular pressure and asymmetric cupping of 0.6 and 0.4 in the right and left eyes, respectively. While normal tension glaucoma was a possible diagnosis, her bilateral optic nerve head pallor, thinning of the RNFL, and VF defects that did not match the cupping raise suspicion of an intracranial lesion. Magnetic resonance imaging (MRI) and histopathology confirmed a large planum sphenoidale meningioma, which was surgically resected. Postoperative recovery showed drastically improved VF and resolution of symptoms, though visual acuity remained suboptimal.</p><p><strong>Conclusion: </strong>Surgical resection of a large tumor size, as seen in our patient, can still result in visual field improvement despite suboptimal recovery of visual acuity. This case highlights the importance of considering intracranial tumors in the differential diagnosis to prevent long-term visual impairment.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"582-589"},"PeriodicalIF":0.6,"publicationDate":"2025-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503545/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The term "acute zonal occult outer retinopathy (AZOOR) complex" encompasses a group of conditions associated with photoreceptor damage, and most patients with AZOOR complex experience irreversible visual-field defects and retinal pigment epithelium atrophy with no effective treatment. Herein, we report two cases of AZOOR complex in which multimodal imaging, including color scanning laser ophthalmoscopy (SLO) and en face optical coherence tomography (OCT) angiography (OCTA), facilitated diagnosis and monitoring.
Case presentation: Case 1 involved a 23-year-old woman who presented with visual-field disturbances in the left eye. The OCT B-scan revealed ellipsoid zone (EZ) irregularities, and color SLO and en face OCTA of the EZ slab showed corresponding hyporeflective areas in the green channel and hypointense regions, respectively. Case 2 involved a 38-year-old woman with decreased visual acuity in the left eye. Imaging findings were similar to those in case 1, and color SLO and en face OCTA revealed abnormalities corresponding to the EZ disruption. In both cases, follow-up imaging revealed improvement in EZ integrity and corresponding changes in color SLO and OCTA findings.
Conclusion: Multimodal imaging using color SLO and en face OCTA provide valuable information regarding the extent and progression of photoreceptor damage in AZOOR complex, which supplement the conventional OCT B-scan findings. These modalities may enhance the diagnostic accuracy and monitoring of patients with AZOOR complex.
{"title":"Usefulness of Color Laser Scanning Ophthalmoscopy and Optical Coherence Tomography Angiography in the Diagnosis of Acute Zonal Occult Outer Retinopathy Complex: A Report of Two Cases.","authors":"Hiroki Kawano, Mitsuyoshi Kubota, Toshifumi Yamashita, Keita Yamakiri, Taiji Sakamoto, Hiroto Terasaki, Akinori Uemura","doi":"10.1159/000547672","DOIUrl":"10.1159/000547672","url":null,"abstract":"<p><strong>Introduction: </strong>The term \"acute zonal occult outer retinopathy (AZOOR) complex\" encompasses a group of conditions associated with photoreceptor damage, and most patients with AZOOR complex experience irreversible visual-field defects and retinal pigment epithelium atrophy with no effective treatment. Herein, we report two cases of AZOOR complex in which multimodal imaging, including color scanning laser ophthalmoscopy (SLO) and en face optical coherence tomography (OCT) angiography (OCTA), facilitated diagnosis and monitoring.</p><p><strong>Case presentation: </strong>Case 1 involved a 23-year-old woman who presented with visual-field disturbances in the left eye. The OCT B-scan revealed ellipsoid zone (EZ) irregularities, and color SLO and en face OCTA of the EZ slab showed corresponding hyporeflective areas in the green channel and hypointense regions, respectively. Case 2 involved a 38-year-old woman with decreased visual acuity in the left eye. Imaging findings were similar to those in case 1, and color SLO and en face OCTA revealed abnormalities corresponding to the EZ disruption. In both cases, follow-up imaging revealed improvement in EZ integrity and corresponding changes in color SLO and OCTA findings.</p><p><strong>Conclusion: </strong>Multimodal imaging using color SLO and en face OCTA provide valuable information regarding the extent and progression of photoreceptor damage in AZOOR complex, which supplement the conventional OCT B-scan findings. These modalities may enhance the diagnostic accuracy and monitoring of patients with AZOOR complex.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"711-719"},"PeriodicalIF":0.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that primarily affects young men, leading to subacute, painless, bilateral loss of central vision. It is caused by point mutations in mitochondrial DNA, especially those involving the MT-ND1, MT-ND4, and MT-ND6 genes, which disrupt complex I function in the mitochondrial respiratory chain.
Case presentation: We describe an 18-year-old male cricket player who presented with a 6-month history of gradually worsening, painless visual loss in both eyes. His best corrected visual acuity was 6/60 in the right eye and 3/60 in the left eye. Color vision was reduced in the left eye but improved when tested with a red filter, raising suspicion of optic nerve pathology. Fundus examination revealed subtle hyperemic optic discs, and visual field testing identified central and paracentral scotomas. MRI of the orbits showed bilateral T2 hyperintensities in the intraorbital portions of the optic nerves. Genetic testing confirmed a homoplasmic MT:14484C>T mutation in the MT-ND6 gene. The patient also reported systemic symptoms including palpitations and excessive sweating. Cardiac evaluation revealed mitral valve prolapse, sinus tachycardia, and elevated blood pressure. These findings led to a diagnosis of Leber's hereditary optic neuropathy plus (LHON plus). He was started on coenzyme Q10 and oral nutritional supplements. Remarkably, over the course of a year, he regained full visual acuity with only residual optic disc pallor.
Conclusion: This case underscores the importance of considering LHON plus in young patients with bilateral optic neuropathy and systemic features, particularly when the MT:14484C>T mutation is present, as early mitochondrial support can lead to favorable outcomes.
{"title":"Visual Recovery in Leber's Hereditary Optic Neuropathy Plus: A Case Report and Literature Insight.","authors":"Radhika Paranjpe, Himani Yadav, Preethi Abraham, Kalibo Jakhalu","doi":"10.1159/000547946","DOIUrl":"10.1159/000547946","url":null,"abstract":"<p><strong>Introduction: </strong>Leber's hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial disorder that primarily affects young men, leading to subacute, painless, bilateral loss of central vision. It is caused by point mutations in mitochondrial DNA, especially those involving the <i>MT-ND1</i>, <i>MT-ND4</i>, and <i>MT-ND6</i> genes, which disrupt complex I function in the mitochondrial respiratory chain.</p><p><strong>Case presentation: </strong>We describe an 18-year-old male cricket player who presented with a 6-month history of gradually worsening, painless visual loss in both eyes. His best corrected visual acuity was 6/60 in the right eye and 3/60 in the left eye. Color vision was reduced in the left eye but improved when tested with a red filter, raising suspicion of optic nerve pathology. Fundus examination revealed subtle hyperemic optic discs, and visual field testing identified central and paracentral scotomas. MRI of the orbits showed bilateral T2 hyperintensities in the intraorbital portions of the optic nerves. Genetic testing confirmed a homoplasmic MT:14484C>T mutation in the <i>MT-ND6</i> gene. The patient also reported systemic symptoms including palpitations and excessive sweating. Cardiac evaluation revealed mitral valve prolapse, sinus tachycardia, and elevated blood pressure. These findings led to a diagnosis of Leber's hereditary optic neuropathy plus (LHON plus). He was started on coenzyme Q10 and oral nutritional supplements. Remarkably, over the course of a year, he regained full visual acuity with only residual optic disc pallor.</p><p><strong>Conclusion: </strong>This case underscores the importance of considering LHON plus in young patients with bilateral optic neuropathy and systemic features, particularly when the MT:14484C>T mutation is present, as early mitochondrial support can lead to favorable outcomes.</p>","PeriodicalId":9635,"journal":{"name":"Case Reports in Ophthalmology","volume":"16 1","pages":"686-692"},"PeriodicalIF":0.6,"publicationDate":"2025-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12503776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145249967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}